AstraZeneca Pharma India has signed a Letter of Intent (LoI) with Strand Life Sciences (Strand), a genomics research and diagnostics company and a subsidiary of Reliance Industries. The LoI aims to explore opportunities to collaborate in healthcare in India.
AstraZeneca Pharma India is a global biopharmaceutical company. The company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease.